Peptide and Protein Drug Delivery Specialists are experts focused on developing advanced systems to optimize the delivery of biologic drugs, including peptides and proteins, to patients. Due to the inherent challenges of these molecules, such as their large size, instability, and poor permeability through biological membranes, they require specialized delivery techniques. These specialists use cutting-edge technologies like nanoparticles, liposomes, and polymer-based carriers to enhance the stability, bioavailability, and targeted delivery of peptides and proteins. Their goal is to ensure that these therapeutic proteins reach the desired target site effectively while minimizing side effects and avoiding degradation in the body.
These professionals work closely with multidisciplinary teams to design and improve drug formulations aimed at treating complex diseases such as cancer, diabetes, and autoimmune disorders. They focus on optimizing the pharmacokinetics of peptides and proteins, including enhancing their half-life and ensuring controlled release. By developing innovative delivery methods, these specialists not only improve the effectiveness of biologic therapies but also reduce the need for frequent dosing. Their expertise in overcoming biological barriers helps maximize the therapeutic potential of these treatments. Through their work, peptide and protein drug delivery specialists play a crucial role in advancing the treatment landscape, offering patients more precise, efficient, and personalized care.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada